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Abstract
The gap between treatment development and efficacy testing to scaled up implementations of
evidence base treatment (EBT) is an estimated 20 years, and hybrid research designs aim to reduce
the gap. One was used for a multisite study in cancer control, testing co-primary aims: 1)
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determine the feasibility and utility of a flexible EBT implementation strategy, and 2) determine
the clinical effectiveness of an EBT as implemented by newly trained providers. Therapists from
15 diverse sites implemented the biobehavioral intervention (BBI) for cancer patients (N=158) as
part of standard care. For implementation, therapists determined treatment format, number of
sessions, etc. and reported session-by-session fidelity. Patients completed fidelity and outcome
assessments. Results showed therapists BBI implementation was done with fidelity, e.g., session
“dose” (59%), core content coverage (60–70%), and others. Patient reported fidelity was favorable
and comparable to the BBI efficacy trial. Effectiveness data show the primary outcome, patients’
scores on the Profile of Mood States total mood disturbance, significantly improved (R2=0.06, β=
−0.24, p < 0.01) as did a secondary outcome, physical activity (R2=0.02, β=0.13, p < 0.05). This
first use of a hybrid design in health psychology provided support for a novel strategy that allowed
providers implementation flexibility. Still, the EBT was delivered with fidelity and in addition,
therapists generated novel procedures to enhance setting-specific usage of BBI and its ultimate
effectiveness with patients. This research is an example of translational research spanning theory
and efficacy tests to dissemination and implementation.

Keywords
Hybrid design; evidence based treatment; clinical effectiveness; implementation
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In an Institute of Medicine report, Crossing the quality chasm: A new health system for the
21st century (Institute of Medicine, 2001), the lag time in translation between research to
health care practice implementation was estimated to be 20 years, due to the failure to move
treatment development and testing to scaled up implementations. Bridging the chasm is
challenging as an analysis of contributory factors suggests. A key one is separateness of two
research traditions. In clinical research, progress is linear, from efficacy to effectiveness
studies, with the latter focus on generalizability of the treatment to other patient groups,
locales of treatment delivery being in “the real world,” and evidence that the treatment, even
with these transitions, can still achieve clinical (patient) and other (quality of life, cost
reduction) outcomes. Quite apart is the domain of implementation, which assumes treatment
effectiveness and focuses instead on treatment delivery, i.e., its fidelity and the generality of
adoption among providers or in systems of care, including the discovery of facilitating and
inhibiting factors at each level. “Pure forms” of each differ in the role of randomization, the
unit of analysis, the nature of the intervention, and the measured outcomes. The respective
contributions are relevant to the other but are mainly nonoverlapping, and notions of
adjusting clinical research aims/designs to those of implementation (or vice versa) has been
likened to “adapting square pegs to fit in round holes” (Onken, Carroll, Shoham, Cuthbert,
& Riddle, 2014, p. 25). However, one pathway across the chasm may be a blending of each
research tradition, thereby achieving more effective implementations and more rapid
translation.
An effectiveness-implementation hybrid design as described by Curran, Bauer, Mittman,
Pyne, and Setler (2012) is one with, a priori, a dual focus. Three types have been described,
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with the type 1 hybrid testing effects of a clinical intervention on patient outcomes while
observing and gathering information on implementation and type 3 testing an
implementation strategy in terms of reach, acceptance, implementation, and sustainability
(Glasgow, Vogt, & Boles, 1999), for example, while secondarily gathering information on
the intervention’s patient outcomes. That used here, type 2, is a dual testing of a clinical
intervention and an implementation strategy to support rapid translation. For a clinical
intervention test, at least 1 outcome is measured and at least 1 hypothesis is examined.
Regarding the implementation test, it assesses adoption of the clinical treatment and the
fidelity of doing so. The test is conducted under a pragmatic set of conditions (rather than
under “best” or “worse” case scenarios) to provide more valid estimates of clinical
effectiveness.
Translational Discovery Leading to the Hybrid Design

Author Manuscript

Science leading to the described study is depicted in Fig. 1. This figure considers models of
Khoury et al. (2010) and Onken et al. (2014). Boxes represent empirical efforts and
pathways represent theory.
Box A: Scientific discovery (Andersen, Goyal, Westbrook, Bishop, & Carson, 2017).
Studies conducted worldwide have documented the stress and quality of life disruption of
cancer. Our work has highlighted an often-unrecognized aspect, i.e., cancer stress promotes
a cascade of negative sequelae – some biologic, others behavioral – which, in turn, have
their own negative consequences and impact the “whole cancer patient”

Author Manuscript
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Path T1: Biobehavioral model of cancer stress and disease course (Andersen, Kiecolt-Glaser,
& Glaser, 1994). A theory (see Fig. 2) conceptualized cancer stress and the accompanying
biobehavioral responses leading to their hypothesized relationship to disease progression.
Briefly, stress and depressive symptoms peak at diagnosis, they are accompanied by biologic
changes (Andersen et al., 1998), and, if continued, quality of life declines (Golden-Kreutz et
al., 2005). Negative health behaviors (e.g., alcohol use, smoking) may increase with stress
(e.g., Armeli, Todd, & Mohr, 2005) and intensify its physiologic effects (e.g., Díaz et al.,
2002). Stress is a correlate of poor treatment compliance (e.g., Arrieta et al., 2013); patients
becoming clinically depressed are more likely to discontinue treatment or die from it (e.g.,
Loberiza et al., 2002). Central nervous system (CNS) and neuroendocrine pathways leading
to immunity are hypothesized. Stress and negative affect can contribute to dysregulation of
the hypothalamic-pituitary-adrenal (HPA) axis (Thornton, Andersen, & Blakely, 2010) and
decreased cellular immunity (Thornton, Andersen, Crespin, & Carson, 2007). Innate
immune processes play a role in both cancer and depression and are thus also included.
Systemic inflammation occurs when cancer cells are identified as foreign and/or when the
tumor itself releases proinflammatory cytokines (Coussens & Werb, 2002). Even after the
tumor is removed, inflammation can be triggered by adjuvant treatments, and inflammation
predicts increased risk of recurrence and cancer death (Molica et al., 2002; Shankar et al.,
2006). Regarding depression, several studies have demonstrated that depressed cancer
patients show innate immune activation (e.g., Irwin & Miller, 2007). Considering a negative
feedback loop (depression←inflammation), proinflammatory cytokines, including TNFalpha, IL-1, and IL-6, interact with CNS pathways to regulate behavior. The latter pathways
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may generate “sickness behaviors”(Dantzer, 2009), with neurovegetative signs and affective
symptoms (fatigue, pain, sleep problems, cognitive impairment, depression).

Author Manuscript

Box B1: Test of the biobehavioral model and development of the intervention (Andersen et
al., 2004, 2007, 2008, 2010). A RCT was designed to answer the following: “Would receipt
of a psychological intervention designed to reduce stress and improve behavioral responses
reduce the risk for disease progression?” Newly diagnosed patients (N=227) with Stage II/III
breast cancer were randomized to Assessment only or Intervention plus Assessment arms.
The model guided the design of a multicomponent biobehavioral intervention [(BBI), i.e.,
understanding and reducing stress, disease/treatment information, problem solving, assertive
communication, social support, body image/sexuality, and health behaviors]. It was
delivered in a group format of 18 weekly sessions (intensive phase) followed by 8 monthly
sessions (maintenance phase). Trial data showed robust, durable gains across secondary
outcomes (i.e., reduced negative mood and physical symptoms, increased social support and
health behaviors, more favorable chemotherapy dose intensity) for the Intervention arm in
contrast to Assessment only; T cell immunity was also enhanced. The maintenance sessions
were important for retaining (and accelerating) patient gains through 12 months. Study of
the subgroup of patients with moderate to severe depressive symptoms showed the BBI
reduced depressive symptoms but also inflammation (Thornton, Andersen, Schuler, &
Carson, 2009). Notably, after a mean of 11 years, the BBI arm had a reduced risk of breast
cancer recurrence [Hazard Ratio (HR)=0.55 (95% CI 0.32–.96), p=.034] compared to
Assessment only patients. Even for those who did recur, BBI arm patients versus
Assessment only patients had significantly improved psychological, social, and immune
responses in the 12 months following recurrence diagnosis and a lower risk of breast cancer
death [HR 0.35 (95% CI 0.17–0.74), p=0.006].

Author Manuscript

Box B2: BBI generalizability (Brothers, Yang, Strunk, & Andersen, 2011; Thornton et al.,
2014). BBI components have been tailored for high-risk groups. BBI components with
Cognitive Behavioral Therapy (CBT) treated cancer patients with major depressive disorder
and led to depression remission. BBI components were combined with Hope Therapy and
mindfulness to successfully reduce anxiety and improve positive affect and QoL for patients
with gynecologic or breast cancer with recurrence.

Author Manuscript

Path T2: STEPS: Conceptualizing EBT dissemination/implementation (DI; Andersen &
Dorfman, 2016). A determinant framework specified the levels of action and means to
address the DI gap of EBTs in cancer control. STEPS (Setting, Therapist, Education,
imPlementation and Sustainability; see Fig. 3) is multidimensional (setting, therapist,
patient) and multilevel, visually suggesting the increasing effort needed to achieve sustained
EBT implementation. In health psychology there are dissemination studies (e.g., Jones et al.,
2013), though few data on implementations (Kelly et al., 2000). In cancer control there are
isolated studies of dissemination (Clark et al., 2012) and none of implementation (Neta et
al., 2015).
Box C. Test of STEPS and BBI dissemination (Brothers et al., 2015). Guided by STEPS,
multimodal education was offered from 2011 to 2016 in BBI Institutes to oncology mental
health providers. For this, BBI was rebranded as Cancer to Health (C2H)
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[www.cancertohealth.osu.edu] and manuals revised for applicability to newly diagnosed
male and female patients with any disease site and < 8th grade literacy (reading level). BBI
was taught by expert trainers using a combination of lectures (40%), role play and group
discussions (35%), practice experientials (25%), and therapists’ “hands on” familiarity with
the therapist manual and patient guide book. The trainee group was large (N=128) and
professionally and geographically diverse, representing 33 states in the US, Puerto Rico, and
foreign countries (Brazil, Israel, Kenya, and Malaysia), with the majority employed in
community settings. Evaluations of the training were very positive, and trainees evidenced
demonstrable improvements in BBI knowledge and also facility with using the treatment
components clinically in analogue assessments. Training generated positive attitudes toward
and high self-efficacy to use BBI, with each predicting their intentions to use BBI post
Institute.

Author Manuscript
Author Manuscript

Box D1: Test of STEPS and BBI implementation, sustainment (Ryba, Brothers, &
Andersen, 2017). Following the Institutes, therapists received six months of support and
guidance to achieve setting readiness. Support focused on four areas: a) adaptation planning,
i.e., assisting therapists to determine “fit” of BBI with their patients and setting; b) quality
monitoring, i.e., monthly (6) conference calls to review BBI principles, problem solve
implementation challenges, and encouragement to use patient reported outcome measures to
enable therapists to make data-informed clinical decisions; c) marketing materials, e.g., BBI
information sheets; and d) financial, i.e., business plan templates to secure resources for
implementation, if needed. Unlike the majority of implementation efforts, no support was
provided to the setting/organization; therapists alone were responsible for making BBI
happen. Over 75% of therapists participated in the support efforts, with their self-efficacy
and positive attitudes toward EBTs continuing to increase. Therapists’ BBI usage was
impressive; the proportion of therapists’ patients treated with BBI ranged from 58–68%
across 2-, 4-, and 6-month follow-ups, with additional data showing sustained usage at 12months (71%). As predicted by STEPS, both therapists’ positive attitudes toward BBI and
setting factors (supervisors’ positive attitudes) were associated with usage.

Author Manuscript

T3: Understanding implementation at the setting level (Williams, Brothers, Ryba, &
Andersen, 2015). During conference calls, therapists described challenges to
implementation. Qualitative data suggested themes subsequently labeled as person (i.e.,
attitudes, statements, and behaviors of key individuals) and environment (e.g., financial
resources). Both factors influenced how easily implementation barriers could be addressed,
with person support potentially more important. At the environment/setting level, most
barriers could be overcome with more resources, but therapists also reported that some
administrations were unable to prioritize funds for any new EBT offering (not limited to
BBI), in part due to an economic recession. This information was collected across Institutes
and incorporated to enhance trainees’ understanding of potential facilitators/barriers and, in
turn, help in their generation of solutions.
Translational summary—The overarching goal is development and testing of
psychological treatments for cancer patients, understanding the mechanisms of their efficacy,
and promoting dissemination and achieving wide implementation. Basic research and theory
grounded the development and testing of the biobehavioral intervention. Designed for the
Am Psychol. Author manuscript; available in PMC 2020 May 01.
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newly diagnosed, non-metastatic breast cancer patient and offered in a group format, robust
psychological, behavioral, biologic, and disease endpoint effects came from the efficacy
trial. Later data showed the clinical effectiveness of BBI components for targeted treatments.
The DI data demonstrated that therapists could be reliably educated and clinically trained,
empowered with positive attitudes and high intentions to implement, and subsequently show
high, sustained, BBI usage.
A Collaborative Study Using a Type 2 Hybrid Design

Author Manuscript

A multisite translational study was designed to test the “real world” clinical effectiveness of
BBI on cancer patient outcomes and to determine the fidelity of BBI as implemented by
newly trained oncology mental health providers from diverse settings. Using a Type 2
Hybrid design, the test was under conducted “medium” complexity circumstances. That is, it
was not the “worst” because the therapists had been well trained in the content and processes
of BBI usage (see C above) and supported in the earliest months of BBI implementation (see
D1 above). But, it was not the “best” circumstance either, as unlike some implementation
tests (Greenwald, 2000), the period of implementation support had ended, there was no
internal or external support for their conduct of a program evaluation, and no added
advantage in the settings, such as accrual capitation, to enroll patients.

Author Manuscript

To study the clinical effectiveness of BBI, patient reported fidelity and outcome measures
previously sensitive to BBI effects were used. These measures, rather than pragmatic ones,
enabled direct comparison of findings from the efficacy RCT. The Reliable Change Index
(RCI; Jacobson & Truax, 1991) documents the magnitude and reliability of patient
improvement. To study implementation, two DI perspectives were considered. The first was
Landsverk’s (2013) suggestion that fidelity/integrity be built into the research design by
addressing external validity. Thus, a multisite design provided diversity of therapists,
patients, and economic models of care and geographic locales of settings. To further blend
research domains, fidelity as conceived in clinical effectiveness studies was measured:
treatment adherence/differentiation and therapist competence and relational. Secondly,
Chambers, Glasgow and Srange (2013) suggest the ultimate benefit of an EBT is its ability
to “fit” within the setting. Thus, the implementation test used a strategy in which therapists
could determine BBI delivery format, sessions conducted, components used, etc. rather than
proscribing such as is usually the case.

METHODS
Participants

Author Manuscript

Sites—Fifteen facilities in Alabama, California (3), Illinois (2), Indiana, Iowa (2),
Kentucky, Maine, Massachusetts, Pennsylvania, and Texas (2) participated. The majority
(73%) were in the community [hospitals (n=7, 47%), Cancer Support Community (n=3,
20%), oncology practice (n=1, 7%)], while four (27%) were National Cancer Institutedesignated Comprehensive Cancer Centers.
Therapists—Therapists (N=15) were mid age (M=43.4 years, S.D.=10.3, range: 26–62)
and included males (n=3) and females (n=12). Professionally, there were doctoral-level
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psychologists (n=7, 47%), master’s-level social workers (n=6, 40%), a psychology
postdoctoral fellow (n=1, 9%), and a master’s-level mental health professional (n=1, 9%).
They had received their terminal degree 14.3 years previously (S.D.=9.2, range: 1–29), had
been licensed for 11.8 years (S.D.=9.0, range: 1–27), and in their current position an average
of 5.6 years (S.D.=6.6, range: 0.2–24). All were employed full time and, on average, spent
70% (S.D.=22%, range: 30%–100%) of their hours per week in service provision, 18%
(S.D.=21%, range: 0%–70%) on administrative tasks or meetings, and 7% (S.D.=10%,
range: 0%–32%) on teaching/supervision.

Author Manuscript

Cancer patients—Across the sites, 158 patients (median=10; range 2–25) were accrued.
Patients were middle aged (M=53.4 years, S.D.=9.9) and primarily Caucasian (85%) and
female (87%). They had received a minimum of a high school education (98.7%), and many
were employed (47%) with 52% having an annual household income ≤$75,000, and 87%
living in an urban area. Only 51% reported being married. Twelve different cancer sites were
represented, with the most common being breast (54%), gynecologic (19%), and colorectal
(6%). Extent of disease was local (32%) or regional (46%) rather than distant (13%) or
recurrent (13%) and the average time since diagnosis was 2.0 years (S.D.=5.7). At baseline,
71% (112) of patients were in treatment or recovering; 28% were post-surgery, 57%
receiving chemotherapy, 29% receiving radiation, and 1% received a bone marrow
transplant. The remaining 29% (46) had completed treatment longer than 6 months
previously; of these, 20% had received chemotherapy, 20% radiation, and 1% bone marrow
transplant.
Procedures

Author Manuscript
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Providers learned of the BBI Institutes via national listserves [e.g., APA’s Division 12
(Clinical Psychology) and Division 38 (Health Psychology), Association of Oncology Social
Workers], the website (cancertohealth.osu.edu), and word of mouth. During the final
afternoon of training for Institutes 1–5, providers (N = 128) learned of the ongoing Cancer
to Health Implementation (C2H-I) study. Described as a program evaluation of BBI,
therapists learned that a C2H-I Data Coordinating Center (DCC) at The Ohio State
University would administer the study and provide the following: 1) A study coordinator to
answer questions and provide guidance for accrual, data collection, and related matters. 2)
Templates for IRB submission. Settings without a local IRB submitted and had protocols
reviewed through the DCC’s submission to the Ohio State IRB. 3) BBI marketing materials
(e.g. patient brochures). 5) Free patient manuals and relaxation CDs for every patient
accrued. 6) A web based (Qualtrics) site for therapist and patient data collection. 7) Within
60 days of completion of data collection, provision of a site-specific summary and deidentified data set.
Therapists were responsible for IRB submission, patient accrual, and providing information
to patients to enable completion of study measures. Therapists were required to provide data
on BBI components delivered and homework assigned via Qualtrics. Regarding BBI
implementation, it was required that BBI be available as part of standard psychosocial
offerings in the setting. The BBI therapist manuals detailed delivery of 26 sessions (18
weekly intensive, 8 monthly maintenance) in a closed group format. BBI core content was
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stress conceptualization, disease information and MD communication, problem solving,
assertive communication, and social support. Sexuality, body image, and health behavior
(diet, exercise) were also included. The manual detailed component specific coping
strategies (e.g., progressive muscle relaxation for stress conceptualization) and homework
assignments (e.g., practice relaxation 3–4 times, 20 min. each, per week). Therapists were to
assign, monitor, and engage patients sufficiently to achieve patient usage of the strategies at
the recommended level. The patient guidebook summarized session content and had work
sheets to be completed during sessions.

Author Manuscript

During training, it was noted that BBI delivery to individuals was acceptable and was, in
fact, recommended as a strategy for therapists to become facile with the content and
treatment strategies prior to conducting groups. It was made explicit that BBI might require
adaptation to a setting/patient group, with examples provided, such as omitting or shortening
content areas, providing fewer sessions, altering the order of sessions. It was, however,
recommended that any adaptation retain session 1, Stress Conceptualization, and the
teaching of progressive muscle relaxation, with CD provision and app versions available.
Inclusion of maintenance sessions was strongly recommended.

Author Manuscript

IRB documents were uniform in describing procedures of patient accrual and assessment.
Eligibility criteria were the following: new (initial) diagnosis of invasive cancer, age ≥21,
and able to give informed consent. Exclusion criteria were the following: estimated survival
< 2 years; non-ambulatory; concurrent significant sensory deficit or diagnosis of organic
brain syndrome, dementia, mental retardation, or major mental illness (e.g., schizophrenia);
and, non-English speaking. Across sites patients seeking psychosocial services were
assigned to any available therapist. If BBI was an appropriate treatment for an assigned
patient, the therapist considered the inclusion/exclusion criteria. For those meeting criteria
and accepting BBI, patients were informed of the program evaluation study. Across sites, 36
patients approached did not consent to participation. If a group was planned, the nonconsenting individual was included with others who did consent and participate in the
evaluation. Participating patients completed pre/post psychological measures, either using
paper/pencil forms (provided by the therapist but mailed to the DCC) or via Qualtrics
administration on a secure server. Following every BBI session, therapists completed fidelity
measures on Qualtrics.
Measures
Implementation: Fidelity

Author Manuscript

Adherence/differentiation: For each session, therapists reported the following: 1)
Attendance, 2) Format [group (open, closed), individual], 3) Session duration (in minutes),
4) Delivery of each treatment component (yes/no), 5) Delivery/review of homework (yes/no)
by component, and 6) delivery of other interventions.
Competence and relational: Two measures of therapist competence were used (Andersen,
Shelby, et al., 2007). The Component Usage asks a patient to report usage of 11 strategies
(e.g., progressive muscle relaxation practice) during the last month on a nine-point
frequency scale (e.g., 0= not at all, 1=once a month; 2=2–3 times per month; 3=once per
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week; 4=2–3 times a week, 5=4 per week; 6=5–6 per week; 7=once a day; 8=2 or more
times a day). The Component Evaluation uses 14-items to assess the helpfulness of BBI
components/strategies (e.g., “relaxation practice with tapes”), each rated on a 4-point Likert
scale of helpfulness (1=not at all helpful, 2=a little bit, 3=moderately, 4=very helpful). The
patient/therapist relationship was assessed (Andersen, Shelby, et al., 2007). Relational/
Cohesion had 2 items for patients to rate a) felt support during treatment and, b) involvement
in treatment, each on a 10-point scale ranging from 0=not at all supported/involved to
9=extremely supported/involved.
Clinical effectiveness: Patient reported—Measures sensitive to BBI effects were
used. They are reliable, valid, and common to cancer intervention studies (e.g., Antoni et al.,
2001).

Author Manuscript

Individual difference: Cancer stress: Interventions may be differentially effective
depending on initial distress levels. As previously (Andersen et al., 2004), cancer-specific
stress was tested as a covariate of treatment outcome with the Impact of Events Scale (IES;
Horowitz, Wilner, & Alvarez, 1979). Using 15 items, patients rate the frequency of intrusive
thoughts and avoidant thoughts and behaviors in the previous week on a 5-point Likert scale
(0=not at all to 4=often). Items are summed for a score ranging from 0 to 75. Cronbach’s
alpha was 0.86.

Author Manuscript

Primary: Emotional distress: The Profile of Mood States (POMS; McNair, Lorr, &
Droppleman, 1971) has 65 items assessing negative mood (e.g., happy, sad) experienced in
the last week, rated on a 5-point Likert scale (0=not at all to 4=extremely). A Total Mood
Disturbance Score (TMD) score, ranging from −32 to 200, is calculated by summing the
tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia, and confusionbewilderment subscales and subtracting the vigor-activity subscale. Cronbach’s alpha was
0.92.

Author Manuscript

Secondary: BBI component specific measures were used. 1) Social support. The Perceived
Social Support from Family (Procidano & Heller, 1983) scale has 20 items assessing support
needs fulfilled by one’s family. Items are summed and scores range from 0 to 20.
Cronbach’s alpha was 0.70. 2) Sexual functioning. The Sexual Experience Scale (Derogatis
& Melisaratos, 1979) (one item) assesses global sexual satisfaction on 9-point Likert scale
(0=could not be worse to 8=could not be better). 3) Physical activity. The Godin-Shepard
Leisure-Time Physical Activity Questionnaire (PAQ; Godin & Shephard, 1985) is a sevenday retrospective measure of leisure-time physical activity. Responses are transformed to
metabolic equivalent task (MET) values, i.e., the rate of energy consumption during a
specific physical activity. Then, the following health-related categories are used: 2=active
(≥24 METS), 1=moderately active (14–23 METS), 0=insufficiently active (<14 METS). 4)
Dietary habits. The Food Habits Questionnaire (Kristal, Bowen, Curry, Shattuck, & Henry,
1990) has 19 items assessing dietary behaviors, e.g., avoiding fat. Items are scored on a 5point Likert scale (0=usually/always to 3= rarely and 4=not applicable) and then averaged to
provide a total score ranging from 0 to 4, with higher scores indicating greater adherence to
a diet lower in fat and higher in fruits and fiber.
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The representativeness of the C2H-I settings, therapists, and patients were compared to BBI
Institute data (N=99 sites, N=128 therapists) for contextual analysis. For the primary
analyses, data from all sites were merged and checked for anomalies. Descriptive statistics
are reported for implementation fidelity. When relevant, data are compared with those from
the BBI efficacy RCT. Clinical effectiveness is tested with pre-treatment (baseline) to posttreatment change on patient outcome measures using hierarchical multiple linear (HLM)
regression analyses. Assumptions underlying the analyses were checked. The primary
outcome was the POMS total mood disturbance, with the Impact of Events scale (IES) tested
as a moderator. In hierarchical linear model (HLM) regressions, variables were entered in
the following order: (1) baseline IES score; (2) time; and (3) interaction of IES and time in
prediction of POMS. The same procedure, excluding the IES, was used for the secondary
outcomes. Significance was specified at the 0.05 level. All statistical analyses were
conducted using IBM SPSS 22. Additionally, the Reliable Change Index (RCI; Jacobson &
Truax, 1991) was used to determine the magnitude and reliability of patient improvement.
For it, RCI = (x2 − x1)/ 2(SE)2 , where x1 is a patient’s pre-treatment score, x2 is the posttreatment score, and SE represents the standard error of measurement of the measure. A
significant change is indicated by an improvement of RCI*1.96 on the measure. Finally, for
significant clinical outcomes, analyses explored the relationship between change and
treatment fidelity.

RESULTS
Contextual analysis

Author Manuscript

Setting level—Trainees from five BBI Institutes (N=128) came from 99 different settings.
Of them, therapists from 38 sites (38%) expressed interest in participating in C2H-I and 16
(16%) joined. IRB applications were completed an average of 13 months (S.D.=9.1) postInstitute; the Data Coordinating Center (DCC) was the IRB of record for 5 sites. Accrual
began approximately 3 months (S.D.=2.8) later, roughly 1.5 years after completion of
training. Of the 16 sites, 15 sites accrued patients and collected data as of March 2017.
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Therapist level—Of the 128 BBI trainees, 15 became investigators; 5 of the 15 also had
BBI trained co-therapists. The 15 represent 12% of the eligible sample. The 15 therapists
and 5 co-therapists represented 38% of the full-time oncology therapists (52) employed at
these sites. Compared to the trainee group, the C2H-I therapists did not differ in age, years
since terminal degree, licensure, duration of current position, discipline, or time spent in
clinical work or teaching (all p’s > 0.25). The only significant difference was weekly time
spent on administrative tasks (t=−2.45, df=127, p < 0.02), with C2H-I therapists reporting a
greater percentage of time per week, 18% (S.D.=21%) versus 9% (S.D.=13%).
Patient level—Across sites, 158 patients were enrolled (M=10.53). N’s by site were as
follows: Alabama=15; California A=23; California B=11; California C=8; Illinois A=13;
Illinois B=10; Indiana=9; Iowa A=12; Iowa B=11; Kentucky=6; Maine=3; Massachusetts=7;
Pennsylvania=3; Texas A=25; Texas B=2). Of the 158, 1 patient was later found ineligible
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and 24 left treatment, resulting in 133 (84%) patients completing pre- and post-intervention
assessments.
When applying to the BBI Institutes, therapists reported the general characteristics of
patients typically treated (Brothers et al., 2015). Comparison of the C2H-I therapists’
application data with the C2H-I patients showed no differences in ethnicity or income.
However, C2H-I patients were more likely to be female (t=2.27, df=157, p=0.03), Caucasian
(t=2.02, df=157, p=0.05), live in an urban area (t=−10.21, df=155, p < 0.01), and have a
breast cancer diagnosis (t=8.69, df=157, p < 0.01) than the “average” patient treated by all
institute therapists.
Implementation: Fidelity
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Format—In the efficacy RCT BBI was delivered in closed groups, i.e., patient entry at
session 1 and exit at the end of Maintenance (session 26). In C2H-I, eight sites (53%)
conducted closed groups, 5 sites (33%) conducted ‘managed’ open groups, one site (7%)
conducted both open and closed groups, and one site conducted individual treatment only
(7%). Patients in managed open groups completed 26 sessions as follows: 1) Session 1 was
conducted individually. 2) A patient then joined a group as a module was begun (see Table 1
for designation of modules a–d). 3) When a patient completed a–c (regardless of the order),
s/he would begin Maintenance (d). At the patient level, 15% received individual treatment,
50% received treatment in “managed” open groups, and 35% received treatment in closed
groups.
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Duration—For the efficacy RCT, BBI was delivered in 18 weekly sessions (intensive) and
8 monthly sessions (maintenance), with each being 90 minutes. As expected, C2H-I
individual sessions were <60 minutes whereas group sessions were > 60 minutes. The total
number of sessions delivered across sites was 597 (Md=35, range 2–196; see Table 1). Per
site intensive sessions ranged from 3 to 14, with a mean of 10.6 (S.D.=2.91; Md=11.1). The
duration of individual sessions (196 delivered) averaged 39 minutes (S.D.=14, Md=40, range
10–60), open group sessions (279 delivered) averaged 86 minutes (S.D.=12, Md=90, range
19–105), and closed group sessions (122 delivered) averaged 92 minutes (S.D.=14, Md=90,
range 15–120). Ten sites (67%) included maintenance, with a mean of 2.8 sessions
(S.D.=1.78) and a median of 2.75. In comparison to the BBI RCT, C2H-I BBI was
implemented with 59% and 23% of the number of intensive and maintenance sessions,
respectively.
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Content delivery—For the BBI RCT, BBI Session 1 provided a conceptualization for the
stresses of cancer and introduced progressive muscle relaxation, and it was recommended
that C2H-I implementations begin with this key session. The remaining core components are
information and communication, problem solving, assertive communication, and social
support. In C2H-I, core topics were delivered to roughly 60–70% of the patients treated with
BBI (see Table 1). Fewer patients, 50–56%, were provided coverage of sexuality and health
behaviors.
For the BBI RCT, patients were assigned homework at the end of sessions and it was
reviewed at the beginning of the following session. In C2H-I, therapists reported delivering
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homework in the majority of sessions (67%), an average of 6.24 sessions (S.D.=2.73, range:
0.00–10.00) of the 10.69 conducted. Eighty nine percent (89%) of patients had at least 1
session in which homework was reviewed. Homework was most frequently included in the
core component sessions.
Therapist competence and relational—Therapists were responsible for directing
patients to use the BBI coping strategies and communicating a level of compliance (see
“Component usage – BBI Recommended” column in Table 2). Excepting social support (3.5
vs. 4), patients’ reported usage of core strategies exceeded the rate recommended (see Table
2, “Component usage – Reported”). Levels lower than recommended were reported for noncore components: sexuality (M=1.91 vs. 3), indicating that patients used sexuality strategies
(2–3 times per month versus the recommended once per week) and dietary strategies to
reduce fat (M=5.66 vs. 7) and increase fiber (M=5.93 vs. 7).
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Regarding component helpfulness evaluation (rated 0–4; see Table 2), patients found BBI to
be very helpful, with a grand mean across components of M=3.48 (S.D.=0.71). Components
with the highest helpfulness ratings were social support (M=3.70, S.D.=0.60), stress
conceptualization (M=3.65, S.D.=0.58), and assertive communication (M=3.61, S.D.=0.61).
Even sexuality, with the lowest rating (M=3.03, S.D.=0.85), was still regarded as moderately
helpful. Regarding the therapeutic relationship, patients reported high levels of perceived
support (M=7.97, S.D.=1.47) and high involvement in BBI treatment (M=7.52, S.D.=1.60).
Clinical Effectiveness
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Time between pre- and post-intervention assessments averaged 17 weeks (S.D.=5.5 weeks).
The moderator test revealed baseline IES to independently predict pre-to-post change in the
POMS above and beyond the effect of time (β=0.56, p < 0.01), but the interaction of IES and
time was not significant (ΔR2 < 0.001, β=0.01, p=0.96). The latter indicates that regardless
of initial IES magnitude, patients improved. Previously greater POMS improvements were
found for those with initially higher IES scores (Andersen, Farrar, et al., 2007); here, BBI
was effective across patients. As predicted, patients reported significant pre- (M=39.7) to
post-intervention (M=22.7) decreases on the POMS (R2=0.06, β= −0.24, p < 0.01). Also, the
Reliable Change Index indicated POMS improvement was reliable and significant for 26%
of the patients.
For secondary outcomes, there was a significant pre- (M=1.39) to post-intervention
(M=1.52) increase in PAQ physical activity scores (R2=0.02, β=0.13, p < 0.05) with patients
reporting being “moderately active” at pre-and “active” at post. No significant pre/post
changes (ps ≥ 0.06) were found for the remaining secondary measures.
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As in the BBI RCT, moderation analyses tested the relationship between component-specific
outcomes and strategy usage. Change in POMS was tested with stress conceptualization use
and progressive muscle relaxation use, and change in the PAQ was tested with physical
activity strategy use. The moderation effects were not significant (ps ≥ 0.05).
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Correlational analyses related POMS change to all fidelity variables and of them, treatment
format covaried. POMS scores were correlated with BBI format (r=0.25, p < 0.05), such that
patients in groups reported larger POMS decreases than patients treated individually, −16.1
versus −0.1, respectively. Further, POMS scores were correlated with group type (r=0.22, p
< 0.05), such that participants from open groups evidenced larger decreases than patients in
other treatment formats, −18.8 versus −7.7, respectively. Similar analyses examined fidelity
and physical activity (PAQ) scores, finding that PAQ scores were also correlated with BBI
format (r=0.24, p < 0.05), such that patients in groups reported PAQ increases (M=0.15)
while patients treated individually reported PAQ decreases (M=−0.21). PAQ scores were
also correlated with session length (r=0.30, p < 0.01), such that patients whose BBI sessions
lasted longer (i.e., in group treatments) reported greater improvements in PAQ physical
activity scores.
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DISCUSSION

Author Manuscript

The overarching goal to add substantively to both the implementation and clinical
effectiveness literatures was achieved. While there are examples of treatment
implementations “going to scale” (Kilbourne et al., 2012; Solberg et al., 2015), to our
knowledge, this is the first use of a hybrid design in the health psychology DI literature and
more generally, it is one of the few studies of adaptation in the context of implementation
(Chambers, 2018). A type 2 hybrid design studied co primary aims to determine 1) the
feasibility and utility of a flexible EBT implementation strategy, and 2) the clinical
effectiveness of an EBT as implemented by newly trained providers. In this study, adaptation
was anticipated and planned but not regimented (Bell, Marcus, & Goodlad, 2013). Data
detailed the adaptations and showed the BBI to be implemented with fidelity. Sixty to
seventy percent of the core content was provided and homework included, with minimal
additions of other content or strategies by the therapists. Moreover, data suggest the
therapists were competent, with their reports of treatment delivery consistent with patient
reports of treatment receipt/usage, which was high. Patients’ satisfaction with BBI was high
and they viewed their therapists as competent and supportive. Finally, effectiveness data
show significant reductions in patients’ negative moods and for 26% of the sample, the
magnitude being significant and reliable.
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Conditions under which the type 2 design is best used have been described (Curran et al.,
2012). One is having a strong base of indirect evidence for the clinical intervention to be
tested. For BBI, efficacy tests showed it to yield robust positive effects which were
conceptually replicated with studies of tailored versions. All of the latter, however, came
from the same research group with no effectiveness tests by others. Overall, we were aware
of the high uptake of BBI (Ryba, et al., 2017), but neither the fidelity of therapists’
implementations nor impact of BBI on patient outcomes was known. Another condition of
the type 2 design is conduct when there is “implementation momentum.” Specifically, C2H-I
therapists began accrual ten months after their training, consultation for BBI adaptation and
addressing barriers, and implementation support (Williams et al., 2015). More broadly, new
standards and cancer patient guidelines specified the use of EBTs (e.g., “cognitive change,
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biobehavioral strategies… treatments using stress reduction, problem solving, assertive
communication”) (Andersen et al., 2014, p. 1610, 1615). Thus, conditions for a Type II
study were timely.
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The breadth of the fidelity data clarifies the nature of BBI provided, and they show an
adapted BBI (i.e., planned or purposeful changes to the design or delivery of the intervention
to retain fidelity to fundamental elements) rather than a modified one (i.e., planned or
unplanned changes to improve treatment fit, engagement, or effectiveness) (Wiltsey Stirman,
Gutner, Crits-Cristoph, Edmonds, Evans, & Beidas, 2015). We use Wiltsey Stirman et al.’s
(2017) definition of types of content level modifications. Considering them, the data suggest
there was little tailoring (minor alterations), addition or diffusion of non BBI treatments or
components, no shortening of session time, no lengthening of number of sessions or time, or
no repeating of content not proscribed for such. Instead, what occurred was removal or
shortening coverage of non-core components (e.g. health behaviors, maintenance). A novel
“real time” adaptation by some therapists occurred, a reordering of BBI components after
the foundational session. These data shed light on how the BBI was adapted into routine
care, aligning with the growing interest to precisely capture the nature of adaptations of
implemented EBTs (Chambers & Norton, 2016).
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NIH recommendations to achieve treatment fidelity in implementations (Bellg et al., 2004)
were incorporated into the design and conduct of BBI dissemination, support to providers
for implementation, and the type 2 study. This included several elements: a) rigorous BBI
training, also resulting in therapists having high motivation and intent to implement BBI; b)
feedback to therapists on their anticipated adaptations, making clear that drift to non BBI
content or strategies would change an empirically supported treatment to one without
support; c) problem solving implementation barriers; d) providing manuals and supporting
materials for therapists and patients; and, e) implementation support.
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A multicomponent assessment of fidelity was used (Schoenwald, et al., 2011), but there is
currently no standard metric as to what constitutes implementation with fidelity versus not.
Regarding differentiation, the low frequency of “other treatments offered” entries suggested
addition of non-BBI content was negligible. Regarding adherence, the modular/component
structure of BBI facilitated the fidelity analysis. Importantly, the evidence suggests that the
fidelity of BBI implementation was at the least acceptable in overall level, and when
compared to BBI RCT data, implemented met or exceeded several benchmarks. Regarding
adherence, the core components (specific factors) of BBI had the highest levels of delivery,
ranging from 60 to 100% of patients receiving the content. For the non-core content
adherence was lower, in the range of 50–56, perhaps driven by specific circumstances. For
sexuality/body image, therapists were trained, but for the majority this was unfamiliar
content and one that requires considerable practice to achieve facility and comfort with
delivery. For health behaviors, it was suggested that dietary and/or exercise personnel could
be integrated into the sessions as was done in the RCT. Some delivered the content and
others used resource persons and or made referrals. An important element of BBI is in- and
out of session activities/homework, but latter are often removed in routine care (Cook,
Dinnen, Thompson, Siminola & Schnurr, 2014). Yet, therapists reported delivering
homework and reviewing homework in the large majority of sessions. Maintenance is a
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novel aspect of BBI and was important to sustaining change; its inclusion was strongly
recommended to therapists. While two thirds of the sites offered maintenance, the median
number of sessions was one third of the recommended dose. Admittedly, BBI is a lengthy
treatment, comparable to some offerings, such as CBT, though not others. Anecdotally
suggested, historical circumstances may have also been relevant to the discrepancy between
the number of sessions offered (11 intensive) versus sessions manualized (18). Much of the
data collection occurred during an economic recession when personnel budgets for
psychosocial services became even tighter with some organizations not replacing therapists
or pressuring remaining ones to limit session numbers to see more patients.
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The therapist fidelity data are very positive and reflect the competence of the therapists and
patients’ satisfaction with BBI. Importantly, therapists’ reports of component delivery (Table
1) and patients’ reported usage (Table 2) are consistent. Moreover, patients’ reported usage
of core strategies typically exceeded the rate recommended for the RTC. Patients viewed the
therapists as very supportive and BBI as a very helpful treatment, with the rating virtually
identical with those from the RCT (Andersen, Shelby, et al., 2007). Collectively, the fidelity
data show BBI is “implementable,” but contextually, it is a treatment showing high
acceptability, engagement, and satisfaction by therapists and patients. Metrics such as these
provide the rationale and data for managers to advocate for service expansion and for
settings to expand market share.
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The analyses show significant change on the POMS, with large magnitude, reliable mood
improvement for 26%. Physical activity changed significantly with time as it did in the BBI
RCT. Regarding the latter, 71% of the patients were still receiving cancer treatment at
baseline, and maintaining, resuming or beginning physical activity anew during this period
is difficult. We do not know, but the gains might have been greater if more maintenance
sessions had been included as the RCT showed acceleration of gains during maintenance
(Andersen, Shelby, et al., 2007). With the dual aims, we were able to examine the
relationship of fidelity and patient outcome data. Multiple aspects of BBI dose [e.g., number
of sessions (−.033), minutes attended (−.137), receipt of components (<.001 to .135)] and
POMS change showed no relationship, whereas BBI offered in groups was associated with
greater gains. In general, research suggests that when compared to the original, adapted
protocols show small, if any, differences in effects (e.g., Stirman et al., 2017). We do know,
however, if the passage of time accounted any patient improvements.
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The study’s strengths and weakness are considered. The multiple-dimension heterogeneity
of the locales, models of care provision, therapists, and patients are key to the
generalizability and implications of the findings. Comparison amongst the latter was not
intended nor was it possible because of the variable rates of accrual. Unlike the RCT,
therapists came from multiple disciplines, heterogeneous experience levels, included males,
and a range of care circumstances. The therapists spent more time per week on
administrative tasks than the other Institute attendees, perhaps providing the time to manage
study tasks. Unlike the RCT, the patient sample included males, many disease sites, and was
geographically diverse. However, these individuals received treatment, which few cancer
patients do (Owen, Goldstein, Lee, Breen, & Rowland, 2007). While cancer patients with
less economic, educational, and other resources were present, they were under represented.
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Type 2 hybrid designs test clinical and implementation aims, but a “test” need not be a RCT,
and here, two conditions supported the use of a non-randomized Type 2 design. For one,
prior efficacy studies showed robust gains with BBI and prior data showed BBI delivery to
the majority (60–70%) of providers’ patients, suggesting they would be reluctant to offer a
treatment other than BBI. Secondly, the implementation strategy—flexible rather than
proscribed BBI delivery—was neither complex nor taxing for therapists or settings and was,
in fact, an advantageous one to study. Regarding the dual aims, trials can be described in
terms of their original intent using the PRECIS-2 metric (PRagmatic Explanatory
Continuum Indicator Summary; Loudon et al., 2015). By design, this study was pragmatic in
terms of eligibility, recruitment, setting, primary outcome, and primary analysis, but
reflected a stronger efficacy orientation in its organization, flexibility in EBT adherence and
delivery, and follow-up [See Supplementary Materials]. Regarding clinical effectiveness
measures, those from BBI trials were used for explicit comparison. In studies with other
purposes, pragmatic measures, such as those recommended in guidelines for the assessment
of anxiety and depressive symptoms in cancer patients or those included in the PatientReported Outcomes Measurement Information System (PROMIS; see http://
www.healthmeasures.net/explore-measurement-systems/promis) can be chosen. The fidelity
measures reflected current conceptualizations (e.g. Schoenwald et al, 2011). Obtaining
additional specifics of the component delivery (e.g., “Was social support from employers,
friends, family, partner, and children discussed, as is manualized?”) added burden. However,
detail on the nature of EBT adaptations is increasingly important in implementation science
(Chambers & Norton, 2016).
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In conclusion, models describe stages of intervention development, dissemination, and
implementation. The BBI provides one example, moving from theory, RCT and companion
studies, inclusion in treatment guidelines, dissemination, implementation, to this study of
implementation fidelity and patient outcomes. C2H-I was a partnership with front line
providers, which is sorely needed (Cook, 2018), and as such the data sheds light on the
implementation adaptations that occur in routine care. These data show that a strategy of
therapist/setting-directed implementation can still achieve treatment fidelity, and further,
clinically important outcomes for patients in the community. The simultaneous study of the
two challenges of disseminating and implementing mental health treatments—training and
supporting providers and achieving fidelity and documenting patient outcomes—might lead
to the greatest scientific gains in implementation science and clinical effectiveness
knowledge, with this study providing one example toward the ultimate goal of impacting the
health and well-being of cancer patients at the population level.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.

Translational science discoveries (A–E) and theoretical linkages (T1–T5) leading to
improved population health. Discoveries impact (and interact with) other discoveries (e.g.,
D1 leading to B1) in addition to those specified.
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Biobehavioral Model of cancer stress and disease course with inclusion of depression and
inflammation pathways.
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Multidimensional framework of Setting, Therapist, Education, ImPlementation and
Sustainability (STEPS) factors and illustration of increasing activity and engagement
required of therapists and settings to achieved sustained provision of evidence based mental
health treatment to patients.
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1
1
3
1
1

(b) Sexuality

(c) Physical Activity

(c) Diet and Nutrition

(d) Intro. to Maintenance

Other (transition)

Numbers from the 10 of 15 sites that included a maintenance phase.

*

1

(b) Body Image

25

4

(b) Social Support

Homework Review

1

(b) Assertive Comm.

8

2

Maintenance*

2

(a) Problem Solving

1

18

Number of Sessions

(a) Comm./Seeking Info.

(a) Stress Conceptualization

Intensive

Treatment Phase (Module) Component

BBI RCT

6.00 (0.00–10.00)

2.75 (0.23 – 5.00)

NA

0.65 (0.00 – 1.00)

0.86 (0.00 – 1.75)

0.52 (0.00 – 1.50)

0.61 (0.00 – 1.00)

0.72 (0.00 – 1.13)

1.55 (0.00 – 5.00)

1.00 (0.00 – 2.00)

1.02 (0.00 – 1.75)

1.00 (0.00 – 2.00)

1.00 (1.00 – 1.00)

11.10 (3.00–14.00)

Number of Sessions Delivered (Median, Range)

91.8% ( 0%–100%)

47.2% ( 23% – 73%)

NA

41.9% ( 0% – 82%)

56.3% ( 0% – 85%)

51.2% ( 0% – 83%)

50.6% ( 0% – 83%)

55.0% ( 0%–100%)

70.0% ( 0%–100%)

60.6% ( 0% – 86%)

66.3% ( 0%–100%)

67.5% ( 0% – 90%)

100.0% (100%–100%)

Patients Receiving ≥1 Session (Mean %, Range)

C2H-I

C2H-I therapists’ (N=15) reports of fidelity of BBI delivery as measured by number of sessions delivered for each component, with comparison to session
numbers in BBI efficacy RCT (Andersen et al., 2004), and as measured by the percentage of C2H-I patients (n=158) receiving the component.
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2
3
3
4
3
3
4

MD Comm. /Seeking Info.

Problem Solving

Assertive Communication

Social Support

Body Image

Sexuality

Physical Activity

7
7

Dietary Fat

Dietary Fiber

5.93

5.66

4.67

1.91

4.09

3.54

4.36

3.62

3.03

1.83

2.25

1.89

1.96

2.41

2.43

2.35

2.25

2.23

1.86

2.05

SD

3.55

3.53

3.03

3.35

3.70

3.61

3.50

3.34

3.46

3.65

Mean

0.70

0.73

0.85

0.67

0.60

0.61

0.67

0.70

0.77

0.58

SD

C2H-I Reported**

Evaluation (Helpfulness)
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Evaluation is a 4-point scale ranging from 1=not at all helpful to 4=very helpful.

**

Patient reported usage of the component strategies in the last month on the following scale: 0= not at all, 1=once a month; 2=2–3 times per month; 3=once per week; 4= 2–3 times a week, 5=4 per week;
6=5–6 per week; 7=once a day; 8= 2 or more times a day.

*

4

Progressive Muscle Relax.

Diet and Nutrition

5.09

4

Stress Conceptualization
4.21

Mean

C2H-I Reported*

Treatment Component

BBI Recommended

Component/strategy Usage

Patients (N=158) reported fidelity as measured by their self-reported frequency of strategy use for each component, with comparison of recommended
usage in BBI efficacy RCT (Andersen et al., 2004). Fidelity was also measured by patients’ evaluation of the helpfulness of the component and its
strategies.
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